Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CA 2375748 A1 · Owner: Sinuspharma, Inc. · Inventors: Hale, Mary Anne; Munk, James D.; Leivo, Frederick T.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pharmaceutical compositions are described that comprise one or more active ingredients selected from the group consisting of anti-infective anti-, inflammatory and anti-mucolytic agents and particularly to compositions , formulated as a solution in a unit dose for aerosol administration to treat chronic sinusitis. The figure discloses the preferred equipment for aerosolized delivery of pharmaceutical solutions. This nebulizer manufactured , by Pari Respiratory Equipment Inc. for the inventors, produces the desired particle size for affective administration of the solutions in this invention to the sinuses. To use this nebulizer preferably medication is placed in the nebulizer at (A). …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 5, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 5, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 5, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.